ALK inhibitor + HSP90 inhibitor

From the NEJM

A case study of combining AT13387 with crizotinib.

http://www.nejm.org/doi/full/10.1056/NEJMc1410799

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply